Suneel Gupta, Chief Development Officer at Protagonist Therapeutics, Inc (PTGX), sold 5,000 shares at $25.00 ($125K) on 2024-01-09, disclosed to the SEC on 2024-01-11.
Scheduled sale ($125k) by Chief Development Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| Filing → |